Mannkind (MNKD) Total Current Liabilities (2010 - 2026)
Mannkind's (MNKD) quarterly Total Current Liabilities came in at $134.6 million in Q1 2026, up 16.06% year-on-year from $115.9 million in Q1 2025, and down 21.32% on a QoQ basis from $171.0 million in Q4 2025.
Mannkind (MNKD) Total Current Liabilities (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Total Current Liabilities data on file, last reported at $134.6 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 16.06% year-over-year to $134.6 million in Q1 2026; TTM through Mar 2026 was $134.6 million, a 16.06% increase from a year earlier, with the FY2025 full-year figure at $171.0 million, up 108.99% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $134.6 million, down from $171.0 million in the prior quarter.
- Over the last five years, Total Current Liabilities for MNKD reached as high as $171.0 million in Q4 2025 and fell as low as $53.5 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $93.9 million across 5 years, with a median of $96.4 million in 2023.
- Across the five-year window, Total Current Liabilities decreased 26.84% in 2022 and surged 108.99% in 2025, its largest moves.
- Year by year, Total Current Liabilities stood at $67.3 million in 2022, then surged by 54.73% to $104.1 million in 2023, then declined by 21.41% to $81.8 million in 2024, then soared by 108.99% to $171.0 million in 2025, then fell by 21.32% to $134.6 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $134.6 million in Q1 2026, $171.0 million in Q4 2025, and $109.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | 134.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 134.56 Mn |
| Dec 31, 2025 | 171.03 Mn |
| Sep 30, 2025 | 109.13 Mn |
| Jun 30, 2025 | 111.83 Mn |
| Mar 31, 2025 | 115.94 Mn |
| Dec 31, 2024 | 81.84 Mn |
| Sep 30, 2024 | 72.10 Mn |
| Jun 30, 2024 | 80.01 Mn |
| Mar 31, 2024 | 99.90 Mn |
| Dec 31, 2023 | 104.13 Mn |
| Sep 30, 2023 | 96.37 Mn |
| Jun 30, 2023 | 96.97 Mn |
| Mar 31, 2023 | 81.85 Mn |
| Dec 31, 2022 | 67.30 Mn |
| Sep 30, 2022 | 59.60 Mn |
| Jun 30, 2022 | 59.56 Mn |
| Mar 31, 2022 | 53.49 Mn |
| Dec 31, 2021 | 48.35 Mn |
| Sep 30, 2021 | 50.03 Mn |
| Jun 30, 2021 | 60.43 Mn |